Scientists develop nanomaterial that targets cancer cells while sparing healthy tissue
Researchers at Oregon State University have engineered an iron-based nanomaterial that completely eliminated breast cancer tumors in lab mice with no recurrence and no apparent side effects — by generating two types of reactive oxygen simultaneously instead of one, which is a first for chemodynamic therapy. They're now testing it against pancreatic cancer. The usual caveats apply: mice aren't humans, and the path from lab results to clinical treatment is long and uncertain. But complete tumor regression without collateral damage is a result worth watching.